Your browser doesn't support javascript.
loading
Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma.
Phillips, Therese; Millett, Molly M; Zhang, Xiaoling; Jansson, Malinka; Cleveland, Rachel; Simmons, Pauline; Cherryholmes, Gregory; Carnahan, Josette; William, Josette; Spaulding, Betsy; Satnick, Ilana R; Inzunza, H David; Taylor, Clive; Cogswell, John; Novotny, James; Oroudjev, Emin; Winther, Henrik.
Afiliação
  • Phillips T; Agilent Technologies, Santa Clara.
  • Millett MM; Agilent Technologies, Santa Clara.
  • Zhang X; Agilent Technologies, Santa Clara.
  • Jansson M; Agilent Technologies, Santa Clara.
  • Cleveland R; Agilent Technologies, Santa Clara.
  • Simmons P; Agilent Technologies, Santa Clara.
  • Cherryholmes G; Agilent Technologies, Santa Clara.
  • Carnahan J; Agilent Technologies, Santa Clara.
  • William J; Agilent Technologies, Santa Clara.
  • Spaulding B; Spaulding Science Group, Santa Barbara.
  • Satnick IR; Agilent Technologies, Santa Clara.
  • Inzunza HD; Bristol-Myers Squibb Inc., Princeton, NJ.
  • Taylor C; Keck School of Medicine of the University of Southern California, Los Angeles, CA.
  • Cogswell J; Bristol-Myers Squibb Inc., Princeton, NJ.
  • Novotny J; Bristol-Myers Squibb Inc., Princeton, NJ.
  • Oroudjev E; Agilent Technologies, Santa Clara.
  • Winther H; Agilent Technologies, Santa Clara.
Appl Immunohistochem Mol Morphol ; 26(1): 6-12, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29189265

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Antígeno B7-H1 / Nivolumabe / Melanoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Antígeno B7-H1 / Nivolumabe / Melanoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article